Daiwa Health Development Introduces Ground-Breaking Brain Supplement

Key Facts

The supplement is based on several scientific studies that demonstrate the effectiveness of plasmalogen, a type of phospholipid found in high concentrations in the brain, for reducing cognitive decline and improving memory.
For example, a major 2019 study by seven scientists in the Journal of Alzheimer's Disease & Parkinsonism examined 157 patients aged 60-85 with "moderate-to-severe Alzheimer's Disease" and found that those supplemented with plasmalogen (Pls) experienced a significant improvement in cognitive function.
"Orally administered scallop-derived Pls improve cognitive function and that the measurement of blood Pls is valuable to assess the severity and treatment progress in patients with moderate-to-severe A.D.," the study concluded.
Based in California, the company's mission is to develop and provide innovative, high-quality health supplements that support optimal health and well-being.